Published in Transplant Direct on June 05, 2015
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med (2008) 4.32
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med (2008) 2.99
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone. Haematologica (2006) 2.40
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant (2006) 2.37
Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant (2002) 2.01
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol (2004) 1.68
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation (2004) 1.31
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.26
A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee. Xenotransplantation (2006) 1.24
In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody. Hum Antibodies (2004) 1.09
Rituximab and immune deficiency: case series and review of the literature. J Allergy Clin Immunol Pract (2014) 0.99
Bortezomib in kidney transplant desensitization: a case report. Clin Transpl (2009) 0.92
Desensitization in kidney transplantation: review and future perspectives. Clin Transplant (2014) 0.90
Desensitization protocol for highly sensitized renal transplant patients: a single-center experience. Saudi J Kidney Dis Transpl (2011) 0.83
Plasma cells in immunopathology: concepts and therapeutic strategies. Semin Immunopathol (2014) 0.83
Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation. Transplant Proc (2005) 0.83
Early B lymphocyte development: Similarities and differences in human and mouse. World J Stem Cells (2014) 0.83
Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report. Transplant Proc (2011) 0.79
Hepatic Sclerosed Hemangioma: a case report and review of the literature. BMC Surg (2015) 0.80
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma. World J Surg (2017) 0.78
Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation. Hepatol Res (2015) 0.77
Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient. Hepatol Res (2015) 0.75
A case of cholangiolocellular carcinoma featuring intratumoral hepatic artery penetration: A case report. Int J Surg Case Rep (2017) 0.75
A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study. Springerplus (2016) 0.75
Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS One (2014) 0.75
Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey. Transplant Direct (2016) 0.75
Sessile serrated adenoma/polyp leading to acute appendicitis with multiple pyogenic liver abscesses: A case report. Int J Surg Case Rep (2017) 0.75
h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases. Int J Cancer (2016) 0.75
Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma. Anticancer Res (2017) 0.75
Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer. J Pathol (2017) 0.75
h-prune affects anaplastic thyroid cancer invasion and metastasis. Oncol Rep (2016) 0.75
De novo hepatocellular carcinoma developing in the living donor liver grafts: A Japanese multicenter experience. Hepatol Res (2020) 0.75
Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response. Hepatol Res (2017) 0.75
Long-term outcomes after treatment for T1 colorectal carcinoma. Int J Colorectal Dis (2015) 0.75
Application of endobronchial ultrasonography in laparoscopic liver segmentectomy in an animal model. Asian J Endosc Surg (2017) 0.75
Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy. Surg Today (2017) 0.75
Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report. Int J Surg Case Rep (2017) 0.75
Erratum to: Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma. World J Surg (2017) 0.75
Short-term outcomes of laparoscopic surgery in octogenarians with colorectal cancer: a single-institution analysis. Surg Today (2017) 0.75